orbital Atherectomy治疗膝下跛行或慢性肢体威胁性缺血的三年结局
基于LIBERTY研究数据库,分析503例PAD患者(617处股腘/膝下病变)接受轨道旋切术(OA)联合血管内治疗的3年结局。按Rutherford分级分组,跛行患者(RC2-3)的MAE、死亡及大截肢/死亡风险低于CLTI患者;3年生存率分别为84.6%、76.2%、63.7%,免于大截肢率分别为100%、95.3%、88.6%。结论认为辅助OA安全且大截肢率低。
要点
- 跛行患者(RC2-3)的3年MAE、死亡及大截肢/死亡风险低于CLTI患者。
- 3年Kaplan-Meier生存率:RC2-3组84.6%,RC4-5组76.2%,RC6组63.7%。
- 3年免于大截肢率:RC2-3组100%,RC4-5组95.3%,RC6组88.6%。
核心结论
- 对跛行或CLTI患者行外周动脉血管成形术联合辅助OA是安全的,3年随访大截肢率低,证明OA适用于PAD全谱患者。
研究设计与样本
- 基于LIBERTY研究(NCT01855412)数据库,纳入503例PAD患者共617处股腘和/或膝下病变,均接受商用血管内装置联合辅助OA治疗。
- 按基线Rutherford分级分层:RC2-3组214例,RC4-5组233例,RC6组56例,采用Cox回归分析3年随访结局。
主要发现
- OA后 balloon angioplasty使用率>98%,RC2-3、RC4-5、RC6组 bailout stenting率分别为2.0%、2.8%、0%。
- 10.8%的患者发生血管造影并发症,不同临床表现间无差异。
- 3年Kaplan-Meier生存率:RC2-3组84.6%,RC4-5组76.2%,RC6组63.7%。
- 3年免于大截肢率:RC2-3组100%,RC4-5组95.3%,RC6组88.6%。
- 仅在CLTI患者中,基线RC与MAE/死亡复合结局相关,但RC分类不影响TVR、MAE、大截肢或死亡率。
临床怎么用
- 对于跛行或CLTI的PAD患者,可考虑在血管成形术中使用辅助OA,尤其适用于股腘和/或膝下病变。
- 术前Rutherford分级有助于风险分层:RC2-3患者3年预后优于RC4-5及RC6患者。
局限性
- 本研究为基于LIBERTY研究的回顾性数据库分析,非随机对照设计。
- 样本中RC6患者仅56例,亚组结果需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Purpose: To investigate the outcomes of orbital atherectomy (OA) for the treatment of patients with peripheral artery disease (PAD) manifesting as claudication or chronic limb-threatening ischemia (CLTI). Materials and Methods: The database from the LIBERTY study (ClinicalTrials.gov identifier NCT01855412) was interrogated to identify 503 PAD patients treated with any commercially available endovascular devices and adjunctive OA for 617 femoropopliteal and/or infrapopliteal lesions. Cox regression analyses were employed to examine the association between baseline Rutherford category (RC) stratified as RC 2-3 (n=214), RC 4-5 (n=233), or RC 6 (n=56) and all-cause mortality, target vessel revascularization (TVR), major amputation, major adverse event (MAE), and major amputation/death at up to 3 years of follow-up. The mean lesion lengths were 78.7±73.7, 131.4±119.0, and 95.2±83.9 mm, respectively, for the 3 groups. Results: After OA, balloon angioplasty was used in >98% of cases, with bailout stenting necessary in 2.0%, 2.8%, and 0% of the RC groups, respectively. A small proportion (10.8%) of patients developed angiographic complications, without differences based on presentation. During the 3-year follow-up, claudicants were at lower risk for MAE, death, and major amputation/death than patients with CLTI. The 3-year Kaplan-Meier survival estimates were 84.6% for the RC 2-3 group, 76.2% for the RC 4-5 group, and 63.7% for the RC 6 group. The 3-year freedom from major amputation was estimated as 100%, 95.3%, and 88.6%, respectively. Among CLTI patients only, the RC at baseline was correlated with the combined outcome of major amputation/death, whereas RC classification did not affect TVR, MAE, major amputation, or death rates. Conclusion: Peripheral artery angioplasty with adjunctive OA in patients with CLTI or claudication is safe and associated with low major amputation rates after 3 years of follow-up. These results demonstrate the utility of OA for patients across the spectrum of PAD.
引用
- Giannopoulos S, Secemsky EA, Mustapha JA, et al. Three-Year Outcomes of Orbital Atherectomy for the Endovascular Treatment of Infrainguinal Claudication or Chronic Limb-Threatening Ischemia. J Endovasc Ther. 2020. PMID: 32618486. doi:10.1177/1526602820935611
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。